Signal Transduction in Breast Cancer: Silencing the Cross-Talk

By Dr Frank E Jones, Department of Structural and Cellular Biology, Dr Matthew E Burow, Department of Medicine (Hematology & Medical Oncology), Department of Surgery, and Dr Steven M Hill, Department of Structural and Cellular Biology, at Tulane Cancer Center

Dr Frank E Jones undertook his post-doctoral training at Yale University within the Department of Pathology. He accepted a position as Assistant Professor at Tulane University in the Department of Structural and Cellular Biology in June 2001.

Dr Jones' research interests focus on the development of mouse models to study the molecular mechanisms contributing to metastatic breast, ovarian and prostate cancers.

Dr Matthew E Burow carried out his post-doctoral studies at the Tulane/Xavier Center for Bioenvironmental Research and was subsequently appointed as a Research Assistant Professor in the Department of Pharmacology in 2000. In 2002 Dr Burow accepted his current position as an Assistant Professor in the Section of Hematology and Medical Oncology, Department of Medicine, with an appointment as an Adjunct Assistant Professor in the Department of Surgery. His primary research interests focus on understanding the molecular mechanisms that control oestrogen receptor mediated gene expression and anti-oestrogen resistance in breast carcinoma cells, as well as the way that cell survival and apoptotic signalling pathways regulate the progression of breast carcinoma to a hormone independent and drug resistant phenotype.

Dr Steven M Hill undertook his post-doctoral training at the University of Texas Health Sciences Center, San Antonio, in the Medical Oncology section of the Department of Medicine under the tutelage of the late Dr William L McGuire. Dr Hill joined Tulane University in 1989 as an Assistant Professor and is currently Professor of Structural and Cellular Biology at Tulane University Health Sciences Center and holds the Edmond and Lily Safra Chair for breast cancer research. Dr Hill's general research interests focus on defining the mechanisms of cross-talk between G-protein coupled receptor signalling pathways and steroid hormone receptor signalling pathways in breast cancer.